Skip to main content
. 2017 Feb 21;116(7):884–892. doi: 10.1038/bjc.2017.36

Figure 2.

Figure 2

Plasma rucaparib concentration–time profile following i.v. or oral administration. Graph shows the geometric mean plasma concentration of rucaparib in patients in arm A (oral rucaparib) (n=4) who received i.v. and oral doses on days −10 and −5, respectively.